Halozyme Therapeutics | HALO - Nakit Ve Eşdeğer





Nakit Ve Eşdeğer Değişiklik Tarih
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amarin USD 122.8M 25.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Baxter International USD 1.97B 240M 2025-12
Cara Therapeutics USD 20.65M 13.57M 2025-06
Cytokinetics USD 122.52M 102.95M 2025-12
DBV Technologies USD 69.84M 33.37M 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
MannKind USD 74.88M 52.51M 2025-12
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Pfizer USD 1.34B 295M 2025-09
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
United Therapeutics USD 1.56B 217M 2025-12
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12